Bloomberg had a solid segment on the space economy market size, touching on a few players in that area like VC-funded Icon Build out of Austin, along with some sovereign actors and Chinese companies. Science was never my strongest subject, so I leaned into data analysis and doubled down on math and finance instead. I may not understand regolith, but I do get that out of a $3.8T potential market size, $SpaceX(SPCX)$ has the same early mover advantage $Tesla Motors(TSLA)$ had, confirmed by AI by at least 6 years. Short version: I added more under $150. A month ago a trader placed a multi-million trade on 2029 $300 strike calls. Also, an artist contracted payload space for a palm-sized model hous
$Moderna, Inc.(MRNA)$ Merck's market cap is currently 358 Billion. Moderna's market cap is currently 80 Billion. Once Keytruda + Intismeran is approved for melanoma, the rest of the cancer treatment approvals will not be far behind. Priced in? Maybe for the short term, but once revenue starts flowing - not even close. In full-year 2025, Keytruda generated $31.7 Billion in worldwide sales, up 7% year-on-year, and accounted for more than half of Merck's pharmaceutical revenue. Keytruda was about half of Merck's total sales for 2025. Keytruda is used for 20 types of cancer, including melanoma. Since the combination of Keytruda and Intismeran reduced death and recurrence for melanoma in a statistically significant and clinically meaningful way (4
$SK hynix(SKHY)$ Is this real? The company is valued at 5X its past year revenue, and the stock price is 5X its past year earnings. And both are growing. If you were buying the grocery store or gas station in your neighborhood as a business, you would have to pay a higher cap rate for it. This is an advanced tech company, not a neighborhood gas station.
$Moderna, Inc.(MRNA)$ Still going strong. For those into bottom fishing and technicals, $Rivian Automotive, Inc.(RIVN)$ has a similar setup to what MRNA had when I was picking it up for dirt cheap at $24-25. The multi-year consolidation is the key part.
Being short semiconductors in 2026 is financially irresponsible. It's earnings season, and bears will be crushed. $Direxion Daily Semiconductors Bear 3x Shares(SOXS)$ could be back in the 20s by mid next month. On top of that, we're entering the most bullish season for US equities.
$IREN Ltd(IREN)$ More than half of IREN's market cap is free cash. Their prepayment structure basically works like 0% interest loans to fund capex, and they own over 5 GW of grid to build and connect to in a premium energy market state. They still need to deliver on checkpoints, for sure. Their CEO stimulus packages are tied to shareholder value and have a 2-year runoff, meaning they need to maintain that shareholder value until 2033 to collect. But some people will keep going on about how it's trading on liquid this weekend.